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Understanding why the response to infection varies between individuals remains one
of the major challenges in immunology and infection biology. A substantial proportion
of this heterogeneity can be explained by individual genetic differences which result in
variable immune responses, and there are many examples of polymorphisms in nuclear-
encoded genes that alter immunocompetence. However, how immunity is affected by
genetic polymorphism in an additional genome, inherited maternally inside mitochondria
(mtDNA), has been relatively understudied. Mitochondria are increasingly recognized as
important mediators of innate immune responses, not only because they are the main
source of energy required for costly immune responses, but also because by-products
of mitochondrial metabolism, such as reactive oxygen species (ROS), may have direct
microbicidal action. Yet, it is currently unclear how naturally occurring variation in mtDNA
contributes to heterogeneity in infection outcomes. In this review article, we describe
potential sources of variation in mitochondrial function that may arise due to mutations in
vital nuclear and mitochondrial components of energy production or due to a disruption
in mito-nuclear crosstalk. We then highlight how these changes in mitochondrial function
can impact immune responses, focusing on their effects on ATP- and ROS-generating
pathways, as well as immune signaling. Finally, we outline how being a powerful and
genetically tractable model of infection, immunity and mitochondrial genetics makes the
fruit fly Drosophila melanogaster ideally suited to dissect mitochondrial effects on innate
immune responses to infection.
Keywords: Drosophila melanogaster, cybrid, infection, innate immunity, mitochondria, mtDNA, oxidative
phosphorylation, reactive oxygen species
INTRODUCTION
Understanding why individuals vary in their response to infection is one of the major challenges in
immunology (1, 2). This variation may arise from differences in host age (3), sex (4), nutrition
or environmental stressors (5), and genetic variation present in immune related genes (2).
Experimental immunology – mainly in model systems such as mice, zebra fish and fruit flies –
has been successful in identifying the major immune pathways (Drosophila innate immunity
summarized in Box 1) (6–8). Quantitative genetic and genomic approaches have identified
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BOX 1 | Drosophila innate immunity in a nutshell. Drosophila has been extensively utilized as a model system for innate immunity and it has led to many
breakthrough in immunity field (6, 114, 115). Drosophila does not possess acquired/adaptive immunity and it relies on humoral and cell-mediated innate immunity for
its defense against pathogens, such as bacteria, viruses, fungi, and parasites. Immune mechanisms against these invaders include activation of appropriate signal
transduction pathways depending on the invading microbe, involving production of antimicrobial peptides (AMPs), phagocytosis of microbes, wound closure, and a
melanization cascade involved in the encapsulation of foreign elements. Similar first-line innate immune defense mechanisms can be found from plants to humans.
Humoral Innate Immunity: In Drosophila, the humoral innate immune response to bacterial pathogens is characterized by the production and release of a cocktail
of AMPs into the hemolymph. This response is driven by two evolutionarily conserved and largely independent pathways, Immune deficiency (IMD) and Toll pathways
(116). The Toll pathway is induced by bacteria containing LYS-type peptidoglycan in their cell walls (mainly Gram-positive bacteria), while the IMD pathway is induced
by DAP-type peptidoglycan (mainly Gram-negative) bacteria. These pathways culminate in the translocation of NF-κB dimers to the nucleus leading to
infection-specific upregulation of AMPs targeted to clear the infection (117–119). The response to viral pathogens replicating within the host cells involves both the
Janus kinase/signal transducers and activators of transcription (JAK-STAT) pathway (118, 120), RNA interference (RNAi) and antiviral effector molecules (121, 122).
Viral infections involve cell-mediated responses like apoptosis and autophagy and humoral responses such as the expression of anti-viral genes, some of which
overlap with genes induced upon bacterial and fungal infections, indicating the involvement of the NF-κB signaling upon viral infections. The response to fungal
invaders includes both humoral and cellular arms of immunity and involves the expression of AMPs mainly via the Toll pathway.
Cell-Mediated Innate Immunity: In Drosophila, the cell-mediated innate immune system consists of hemocytes (blood cells) and is induced by epithelial damage
and detection of foreign particles in the hemocoel. Hemocytes function in sealing of epithelial wounds, encapsulating and terminating parasites and engulfing
apoptotic corpses [reviewed in (123)]. In Drosophila there are three major lineages of hemocytes: plasmatocytes (phagocytic), crystal cells (melanization) and
lamellocytes (encapsulation). Plasmatocytes comprise the majority of the circulating hemocyte population and are responsible for the engulfment of small particles,
participate in the encapsulation of foreign material and are able to trigger the systemic humoral immune response to secrete AMPs. Crystal cells usually make up less
than 5% of the larval circulating hemocytes. Crystal cells contain prophenol oxidase which active form phenol oxidase is involved in the melanization cascade when
the crystal cells rupture in response to immune activation (123). In uninfected larvae, the lamellocytes can be present in small numbers in the late third instar stage,
otherwise healthy larvae do not contain them. Lamellocytes are produced upon invasion of parasitoid wasps and they form a multilayer capsule around the invading
parasitic egg, with the help of plasmatocytes and crystal cells (124). Eventually the capsule is melanized and elevated levels of ROS terminate the intruder (125).
polymorphisms in genes underlying these mechanisms, and these
explain some of the variation in infection outcomes (9–12).
While most of this work has focused on genetic variation in
the nuclear genome, metazoan organisms have an additional
genome, inherited maternally inside mitochondria (mtDNA).
More than functioning as the powerhouses of the cell, a growing
body of work in the last decade has shown that mitochondria play
an important role in inflammation and immunity and contribute
to the host response to infection (13–18).
Here, we propose that the fruit fly (Drosophila melanogaster)
offers an ideal model system to investigate the role of
mitochondrial variation and mito-nuclear crosstalk in
innate immunity. We start by discussing the sources of
variation in mitochondrial function, using examples of
mutations of nDNA and mtDNA encoded genes that have
been shown to affect organismal phenotypes through changes
in mitochondrial metabolism and signaling. This is followed
by emphasizing the emerging role of mitochondria in immune
responses through mitochondrial metabolites and by-products
of mitochondrial metabolism, such as ROS. Finally, we
describe methodology to investigate the role of mito-nuclear
crosstalk and mtDNA variation in immunity in Drosophila.
We emphasize how the use of cytoplasmic hybrid (cybrid)
models allows to distinguish the effect of mtDNA variation
from that arising from the nuclear genome. We conclude
by highlighting the benefits of the cybrid model to further
our understanding of mito-nuclear effects on heterogenous
immune responses.
Abbreviations: AMP, antimicrobial peptide; ATP, adenosine triphosphate;
DAMP, danger-associated molecular pattern; ETC, electron transport chain;
IMD, immune deficiency; mt-aaRS, mitochondrial aminoacyl-tRNA synthetase;
mtDNA, mitochondrial DNA; mtROS, mitochondrial reactive oxygen species;
nDNA, nuclear DNA; NF-κB, nuclear factor kappa-light-chain-enhancer of
activated B cells; OXPHOS, oxidative phosphorylation; ROS, reactive oxygen
species.
SOURCES OF MITOCHONDRIAL
VARIATION
Mitochondrial function depends on ∼1200 – 1500 proteins,
the majority of which are encoded by the nuclear genome
and transported to the mitochondria (19). Cellular energy
production relies on mitochondria to produce ATP via oxidative
phosphorylation (OXPHOS). OXPHOS requires the coordinated
function of multiple protein subunits encoded by both the
nuclear and mitochondrial genomes (nDNA and mtDNA,
respectively – Box 2), and therefore both anterograde (from
nucleus to mitochondria) and retrograde (from mitochondria
to nucleus) signaling is required for optimal mitochondrial
function. Mitochondrial variation arising from either nDNA
or mtDNA can affect the transcription and translation of the
mitochondrial proteins, signaling between the two genomes
and through changes in the direct physical interactions among
the OXPHOS components originating from the two genomes,
ultimately affecting the function of mitochondria. Mitochondrial
variation shows multiple mode of inheritance. When this
variation originates from mtDNA it is maternally inherited
and has a potential to become heteroplasmic even within
mitochondria, and when originating from nuclear genome it
can be X-linked, autosomal dominant, autosomal recessive or
de novo. Here, we discuss potential sources of mitochondrial
variation with examples of known nuclear and mitochondrial
mutations that could also lead to variation in immune responses.
Variation Arising From the Nuclear
Genome
The vast majority of the proteins that are required for
mitochondrial functions are encoded by the nuclear genome,
translated in the cytosol and transported to mitochondria
via mitochondrial targeting sequence which is removed upon
entry into mitochondria. These proteins include the replication,
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BOX 2 | Mito-nuclear crosstalk is required for mitochondrial functions. Mitochondria are cellular organelles of eukaryotic cells that are thought to have originated by
endosymbiotic phagocytosis of an oxygen-converting α-proteobacterium by archaebacterium (19, 126). The primary function of mitochondria is to produce ATP
through oxidative phosphorylation (OXPHOS) complexes I-V, and mitochondrial matrix is also the site of tricarboxylic acid cycle. Mitochondria contains multiple
copies of a circular mtDNA (mtDNA copy number) distinct from that of the nuclear genome (Figure 1). Majority of the mtDNA genes required for aerobic energy
production through OXPHOS have been shifted to the nuclear chromosomes and the remaining mitochondrial genome in most metazoans encodes for 37 genes, all
crucial in OXPHOS. From these, 13 are polypeptide subunits of four of the five OXPHOS complexes, with the majority of the polypeptides encoded by nDNA
(Figure 1B). Mitochondria contains its own translational system and the mtDNA encodes two rRNA and 22 tRNA genes as the mt-aaRS genes are encoded by the
nuclear genome. Beside the 84 nDNA genes functioning in OXPHOS, around 1200-1500 nDNA encoded polypeptides are imported to and assembled within
mitochondria, required for the various mitochondrial functions (Figure 1A). Nucleus and the mitochondria maintain a bidirectional regulation where the nuclear
genome can signal to the mitochondria (anterograde signaling) for example to increase mitochondrial respiration. Mitochondria can signal (retrograde signaling) for
example to induce cell death by releasing cytochrome c, or by controlling mitochondrial fusion and fission by AMP-activated protein kinase (57).
transcription and translation machineries for mtDNA and the
84 polypeptide subunits needed for OXPHOS (summarized
in Box 2). Mutations in nDNA directly affecting OXPHOS
complex genes have been reviewed in (20). Maintenance
genes of mitochondrial functions include regulatory genes
of mitochondrial and cytosolic nucleotide pools to maintain
balanced supply of mitochondrial dNTPs, involved with mtDNA
nucleoid packaging, carrier proteins required for metabolite and
cofactor transport across cellular and mitochondrial membranes,
genes for mitochondrial lipid and membrane homeostasis,
and mitochondrial fission/fusion and cristae organization
[reviewed in (21)].
Mutations in mtDNA maintenance genes (replication and
repair pathways and mtDNA nucleoid packaging) have been
shown to cause mtDNA deletions, point mutations and even
depletion (22). The most important mtDNA maintenance gene
is the DNA polymerase gamma (POLG) which is responsible
for the replication of the mtDNA. Almost 200 POLG mutations
have been reported and these are the most common causes
of mitochondrial disease. Mutations in POLG have been
shown to cause large scale deletions and various other
mutations to the mtDNA due to replication and/or repair
machinery malfunctions and these have been connected to many
mitochondrial diseases such as Alper’s syndrome, parkinsonism
and multiple other neurodegenerative disorders (23). POLG
was mutated in Drosophila to create a proofreading-deficient
form resulting to drastically increased somatic mtDNA mutation
frequency and mitochondrial dysfunction, which manifested as a
shortened lifespan, a progressive locomotor deficit and a loss of
dopaminergic neurons (24).
Regulation of OXPHOS gene transcription is tightly
coordinated and must be able to establish efficient oxidative
metabolism fulfilling the cell’s changing energy requirements.
Components of the transcription machinery are encoded by the
nuclear genome and have been reviewed in (25). Mossman et al.,
showed that in D. melanogaster cybrid lines the transcription of
nuclear encoded mitochondrial genes were affected by mtDNA
variation, indicating a retrograde signaling effect in transcription
regulation (26). Hence, mutations in the transcription machinery
can have a wide impact on the function of mitochondria, and
variation in the mtDNA genes can affect the overall transcription
efficiency of OXPHOS components, possibly also affecting
their translation.
All proteins involved in mtDNA translation (27) are encoded
by nuclear genes, involving ribosomal proteins, mt-aaRSs, tRNA
modifying enzymes, and translation factors. Mutations in these
genes have been shown to cause mitochondrial diseases due
to dysfunction in the protein-synthesis machinery (27). mt-
aaRSs are transported to mitochondria to catalyze an amino
acid attachment to its complementary tRNA in aminoacylation
reaction for translation of the thirteen mitochondrial proteins.
All ribosomal RNAs and the transfer RNAs required for the
translation of the mitochondrial proteins are encoded by the
mtDNA (Figure 1). Hence, nuclear encoded components of the
translation machinery need to be able to recognize mitochondrial
counterparts for the production of mitochondrial proteins.
mt-aaRS genes are central to cellular energy production and
mutations in these can lead to variable disease phenotypes
depending on the affected tissues and the energy demands of
the cells in those tissue types (28). Mutations in both mt-tRNAs
and mt-aaRSs can lead to disease and the clinical presentation
has been shown to be highly specific to the affected mt-
aaRS [reviewed in (29)]. However, diversity of pathologies is
higher for mt-tRNA mutations than mt-aaRSs, possibly due to
random distribution of heteroplasmic populations of mtDNA
copies during mitotic segregation (28). In Drosophila simulans
a variant of tyrosyl-tRNA synthetase interacts epistatically with
a mitochondrially encoded tRNATyr variant, leading to decrease
in the activities of OXPHOS complexes I, III, and IV (30).
At the organismal level this manifests as developmental delay,
compromised bristle formation and decreased fecundity (30).
In D. melanogaster, a tko mutant (tko25t) carries a missense
mutation in nuclear encoded mitoribosomal protein S12
causing a decrease in smaller ribosomal subunits. This causes
decreased activity levels of all four OXPHOS complexes
that contain mitochondrial encoded proteins (Figure 1),
ultimately manifesting as developmental delay, temporary
paralysis followed from vigorous shaking (bang sensitivity) and
sensitivity to antibiotics and high sugar diet as well as impaired
courtship behavior and hearing (31, 32). Similar defects have been
found in fibroblasts of patients with antenatal encephalopathy
caused by mutations in the MRPS22 gene coding mitochondrial
ribosomal protein, which result in a reduction of 12s rRNA (33).
Variation Arising From the Mitochondrial
Genome
The effect of the mitochondrial genome variation on innate
immunity is intriguing as mtDNA does not follow the traditional
Mendelian inheritance because it is inherited uniparentally
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A
B
FIGURE 1 | Mito-nuclear crosstalk in mitochondrial functions and energy production. (A) Mitochondria rely on coordinated functions of nuclear and mitochondrial
genomes. Vast majority of the genes required for mitochondrial functions are encoded by the nuclear genome. These proteins are translated in the cytoplasmic
compartment and transported into the mitochondrion post-translationally with a mitochondrial targeting signal. Products of both genomes are required for producing
cellular energy in the form of ATP through OXPHOS. As a by-product of OXPHOS mitochondria produces reactive oxygen species (ROS) which are detoxified by
antioxidants. mt-aaRSs, mitochondrial aminoacyl-tRNA synthetases; mt-RPs, mitochondrial ribosomal proteins. (B) OXPHOS takes place at the inner mitochondrial
membrane and it comprises five enzyme complexes. Both nuclear and mitochondrial encoded proteins are required for OXPHOS complexes I and III-V, as complex II
contains only nuclear encoded subunits. Complexes I-IV and two electron carriers form the respiratory chain which generates a proton gradient used by complex V
to generate ATP.
through the maternal lineage. The mitochondrial genome
contains 37 genes, from which 13 encode polypeptides, two
rRNA genes and 22 tRNA genes (Box 2 and Figure 1A) and
pathogenic mutations have been reported in all 37 mtDNA genes
(34). mtDNA is subjected to much higher mutation rates than
the nuclear genome and the mutation rate varies between species
(35, 36). Besides mutations of the mtDNA replication and repair
machinery, higher mutation rate of mtDNA is affected by the
production of ROS within mitochondria as by-product of the
OXPHOS. This can lead to a cycle in which ROS causes DNA
damage, which in turn leads to dysregulation of respiration and
accumulation of mutations.
Each cell contains numerous mitochondria and each
mitochondrion may contain from a few to dozens of copies of
mtDNA (the mtDNA copy number). Hence a given cell of a
specific tissue type may contain thousands of copies of mtDNA
and only one copy of nDNA. Unlike nDNA, mtDNA is not
packed by histones but packed into protein-DNA complexes
called nucleoids (37). Drosophila mtDNA contains one large
A + T rich non-coding region (38), which in humans is called
the D-loop. In both Drosophila and humans, the non-coding
region is the starting point of mtDNA replication (39). Hence,
variation in this region might cause changes in the mtDNA
replication and have an effect on the mtDNA copy number
content (40) and ultimately in energy production. mtDNA
copy number is usually higher in tissues that have high energy
demand such as brain, skeletal, and cardiac muscle tissues (41)
and mtDNA mutations in these tissues can possibly lead to more
pronounced phenotypes.
Besides heritable mtDNA mutations occurring in the germ
line of the maternal lineage, the mtDNA of both females
and males are subjected to spontaneous somatic mutations.
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mtDNA genetics is complicated due to its multi-copy nature.
mtDNA mutations within a single cell (and even within a
single mitochondria) can be either heteroplasmic due to a mix
of mutated and wild type mtDNA, or homoplasmic where all
mtDNAs contain either the mutated or the wild type form. In
a heteroplasmic mutation the proportion of mutated mtDNA
needs to exceed a certain threshold for the mutation to manifest.
This can be due to the wild type mtDNA not being able to
compensate the defect at that point. The threshold is also
likely to be dependent on the mutation type and environmental
effectors. Nuclear genotypes may also have variation in their
ability to dampen or amplify the effects of specific deleterious
mitochondrial mutations, which often demonstrate incomplete
penetrance (42).
mtDNA mutations have been linked to various human
diseases (43). In Leber hereditary optic neuropathy (LHON) the
patient suffers from a loss of vision and the mtDNA mutations
causing it are mostly considered homoplasmic (44). However,
even though all the offspring of a homoplasmic mother inherits
the LHON, only 50% of males and 10% of females develop the
disease, showing that predicting the way the mtDNA mutation
manifests, is difficult due to mito-nuclear crosstalk. Also,
environmental factors can cause changes in the mtDNA mutation
manifestation, as in the case of mtDNA encoded homoplasmic
ribosomal RNA (RNR1) mutation that causes deafness early
on in childhood. Specific antibiotics are associated with the
manifestations of the clinical symptoms of the RNR1 mutation
(45). Due to the complexity of the crosstalk of the two genomes
and environmental factors, possible physiological compensations
and the amplifying or dampening effects originating from nuclear
genome variation and compatibility with the mtDNA, it is
difficult to predict how the mtDNA mutations will eventually
manifest themselves.
Disruption of Mito-Nuclear Crosstalk
The optimal functioning of mitochondria relies on the correct
transcription and translation of genes involved in respiration, and
as mentioned above, these genes are found on both the nuclear
and mitochondrial genomes. Several signaling pathways between
the nucleus and mitochondria have been uncovered recently
(46). Mutations in either nDNA or mtDNA have the potential
to disrupt the crosstalk between mitochondrial and nuclear
proteins, and can therefore disrupt efficient gene transcription
and translation (30), with consequences for metabolic rates (47),
aging (48) and sperm competitiveness (49), which ultimately
have detrimental effects on organismal fitness (50). Evidence for
these detrimental effects is especially clear in hybrids between
closely related species or between divergent populations within
species, where long-term coevolution between the nuclear and
mitochondrial genomes has been broken up, resulting in novel
combinations of nuclear and mitochondrial genomes (51, 52).
For example, hybrids of the marine copepod Tigriopus show
reduced activity of OXPHOS Complex IV (cytochrome c oxidase)
because of the breakup of coevolved nuclear and mitochondrial-
encoded subunits of the Complex IV (51). This mismatch
between nuclear and mitochondrial genes is thought to be
a strong selection pressure for the fixation of compensatory
mutations in nuclear-encoded OXPHOS subunits (53).
Mito-nuclear interactions can also have strong effects on
the outcome of infection. In Drosophila, a mito-nuclear
incompatibility resulted in energetically compromised flies that
were more susceptible to infection by a bacterial pathogen (54).
Salminen et al., identified an OXPHOS Complex III mutation
D21N in D. melanogaster mitochondrial CYTB gene, that was
shown to cause larval stage melanotic nodules in a healthy
nuclear background (6%) and a significant increase (56%) of
melanotic nodules when the mitotype was introgressed into a
tko25t nuclear background (55). Formation of melanotic nodules
is considered a sign of activated cell mediated innate immunity,
and it usually involves the proliferation and aggregation of
hemocytes, Drosophila blood cells (56). Furthermore, CYTB
mutation bearing mitotype in a tko25t nuclear background caused
100% pupal lethality, which is a first report of synthetic lethality
between nuclear-mitochondrial interaction within a metazoan
species (55).
MITOCHONDRIAL VARIATION CAN
AFFECT INFECTION OUTCOME
The role of mitochondria in the response to infection is
central, impacting multiple functions. First, intermediates of the
mitochondrial tricarboxylic acid (TCA) cycle have a signaling
function in innate immune responses. Second, mitochondria
generate energy by producing ATP during OXPHOS (Box 2 and
Figure 1B), and given the elevated energetic requirements of
immunity, we may expect variation in mitochondrial functions
to result in changes in ATP production, thereby generating
heterogeneity in the response to infection. Third, mitochondrial
metabolism may further promote protection against pathogens
by producing ROS, with direct antimicrobial action. Finally, in
mammalian models of immunity, damaged mtDNA has been
shown to act as DAMP triggering inflammatory responses akin
to those seen during infection. There is therefore increasing
evidence that mitochondrial functions contribute to the host
response to infection.
Mitochondrial TCA Cycle Metabolites
With Immune Signaling Functions
Mitochondrial tricarboxylic acid cycle (TCA, also called Krebs
cycle and citric acid cycle) consists of a series of reactions where
substrates originating from carbohydrates, fats and proteins
have been fed into it and the metabolites from the cycle are
transported into cytosol as building blocks for macromolecules
or energy is released through the oxidation of acetyl-CoA.
However, metabolites in the TCA cycle have also been shown
to be involved in regulation of chromatin modifications, DNA
methylation and post-translational modifications of proteins
[reviewed in (57)]. Intermediates and derivatives of the TCA
cycle have been shown to have non-metabolic signaling functions,
in addition to their more conventional role as metabolites
associated with bioenergetics (58). Non-metabolic functions of
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the TCA cycle intermediates succinate, itaconate, fumarate, 2-
hydroxyglutarate and acetyl-CoA play a role in inflammation,
and immune cell activation (58). For example, succinate is a pro-
inflammatory metabolite as its production is enhanced during
inflammation (59) and it acts as a signal from mitochondria
to the cytosol to induce the expression of pro-inflammatory
genes and increases the levels of antioxidant superoxide as a
proinflammatory redox signal (60). Succinate has also been
shown to accumulate in lipopolysaccharide treated macrophages
(59). Itaconate on the other hand is endogenous protective
and anti-inflammatory molecule that negatively regulates the
inflammatory response and cytokine production (61–63) and
also has direct antibacterial effects (64). TCA cycle intermediates
have also been connected to epigenetic signaling (58). For
example, fumarate has a role as an epigenetic inflammatory
signal. Arts et al., showed that the accumulation of fumarate in
immune activated monocytes was needed for trained immunity
by enhancing cytokine production upon re-activation with
lipopolysaccharide (65). Further, Acetyl-CoA has been shown
to drive histone acetylation which can have profound impact
on immune cell function (66). To summarize, mitochondrial
variation may impact infection outcomes via their effect on TCA
cycle products that have immune signaling functions.
Changes in ATP Production
Mitochondria generate energy by producing ATP during
OXPHOS (Box 2), and given the elevated energetic requirements
of immunity, we may expect variation in mitochondrial function
to result in changes in ATP production, thereby generating
heterogeneity in the response to infection (54). Mutations in any
of the nuclear or mitochondrial encoded OXPHOS complexes or
in nuclear genes affecting replication, transcription or translation
of mtDNA can affect the total electron transfer chain outcome,
potentially causing a decrease in the total production of ATP.
Severely decreased ATP synthesis is an obvious problem for cells
with constant high energy demands such as cardiomyocytes and
neurons (67) and decreased ATP synthesis can also increase the
AMP/ATP ratio that can lead to activation of AMP-activated
protein kinase and multiple signaling pathways (46). We might
therefore expect mutations in nuclear or mitochondrial encoded
components that cause a reduction in ATP to result in a decrease
of immune cell function.
Role of ROS in Immune Responses
Reactive oxygen species are a group of reactive molecules and free
radicals derived from molecular oxygen which are now known
to have a role in cellular homeostasis (68). Elevated levels of
ROS can cause oxidative stress, cellular-, and DNA damage in
eukaryotic cells. Mutations in nuclear or mitochondrial genes
encoding the protein subunits of OXPHOS complexes I and
III can cause a decrease or an increase in ROS production,
depending on the mutation. One of the most evident roles of
mitochondrial functions in innate immunity is the production
of ROS by leakage from mitochondrial ETC. The majority of
ROS are produced during mitochondrial ETC (mtROS), and
some by oxidoreductase enzymes such as NADPH oxidase, a
multicomponent membrane bound enzyme complex. Common
ROS include superoxide (O−2), hydrogen peroxide (H202),
hydroxyl radical (OH), hydroxide ion (OH−) and nitric oxide
(NO). Prolonged oxidative stress is harmful and so detoxification
of ROS via scavenging enzymes and antioxidants is vital.
Therefore, mutations in the nuclear encoded antioxidants that
are targeted to detoxify ROS, can also have an impact on
immune response. Antioxidant superoxide dismutase (SOD) is
transported to mitochondria where it converts superoxide to
hydrogen peroxide. Hydrogen peroxide outside mitochondria
is converted to water and oxygen with the help of catalase,
peroxiredoxins and glutathione peroxidases (Figure 1).
mtROS is produced in all cell types that contain mitochondria
and it has been connected to regulation of signaling pathways
(69), apoptosis (70), inflammation (71), cellular adaptation to
hypoxia (72), cellular differentiation (73), and autophagy (74).
In addition to the regulative role of mtROS, a growing body
of evidence has highlighted the role of ROS as a target of
regulation of immune signaling pathways (14, 75). mtROS serves
several roles within both the humoral and cell-mediated arms
of innate immunity, including direct elimination of pathogens
through its microbicidal effects. However, it is still unclear what
is the exact mechanism of the bactericidal effect of mtROS upon
bacterial infection as the effect seem to be the type of ROS and
pathogen specific [reviewed in (68)] and aligns with the increased
heterogeneity of the innate immune response.
Alongside its role in promoting bacterial clearance, mtROS
also functions in signaling for hemocyte proliferation and
differentiation in Drosophila and has been identified as an
essential signaling molecule in Drosophila’s cellular immune
response to parasitoid infection (76). ROS plays a likely role
as a key signaling molecule within the Drosophila lymph gland
as it has been suggested to prime the quiescent hemocyte
progenitors within the lymph gland for differentiation (77). It
has been shown that reduction of ROS significantly retards
progenitor differentiation whereas upregulation of ROS via
OXPHOS Complex I disruption produces a phenotype with a
significantly higher hemocyte population (77).
Transmitochondrial cell lines can be created by combining
enucleated cells that contain the mtDNA of interest with cells that
lack their mtDNA (78). Data obtained from transmitochondrial
cell lines suggest that mtDNA variants on a controlled nuclear
background can alter ROS levels of cells (79). Organismal cybrids
have also been shown to differ in OXPHOS parameters (34)
and effect of mtDNA variation on altered ROS production has
been studied in Drosophila in vivo, showing that specific mtDNA
variants can elevate ROS production (80).
Cytosolic mtDNA as a Danger Signal
During infection, elevated levels of ROS can cause mitochondrial
and cellular damage resulting mtDNA leakage. Due to the
evolutionary origin of mitochondria it harbors resemblance to
bacterial DNA making it appear non-self. mtDNA is surrounded
by a double-membrane structure and membrane damage could
lead to leakage of mtDNA outside mitochondria and elicit self-
derived immune activation. When mtDNA is located outside
mitochondria in the cytoplasm of the cell or in extracellular space,
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it can trigger immune responses by directly engaging the host’s
innate immune pattern-recognition receptors (PRRs) [reviewed
in (81)]. PRRs are conserved receptors that recognize viral,
bacterial and fungal particles as well as molecules released from
injured cells. The release of mtDNA outside of mitochondria
can occur from dying cells, during injury, cellular stress
or infection, and mtDNA outside of mitochondria engages
PRRs and functions as damage-associated molecular pattern
(DAMP) leading to enhancement of pro-inflammatory responses
(71). In mammalian models of immunity, inflammasomes are
innate immune related signaling complexes that monitor the
cytosolic compartment of the cell and are involved in the
secretion of cytokines upon infection and recognition of DAMPs
(81). Altered mitochondrial dynamics, production of mROS
and release of mtDNA outside mitochondria have all been
linked to inflammasome activation (82). In mammalian system
extracellular circulatory mtDNA has been shown to act as an
endogenous Toll-like receptor TLR9 agonist and been connected
to many TLR9- dependent inflammatory diseases (81). Cytosolic
mtDNA (83) as well as cytosolic double-stranded RNA created
during bidirectional transcription of mtDNA (84) has been
shown to trigger antiviral responses in human.
USING DROSOPHILA TO STUDY
MITOCHONDRIAL VARIATION AND
MITO-NUCLEAR INTERACTIONS IN
IMMUNITY
Mitochondrial function and the content of the mitochondrial
genome are highly conserved among metazoans e.g., between
humans and the fruit fly D. melanogaster and the latter has
been widely used to model human mitochondrial diseases
[reviewed in (85)]. Besides studying the naturally occurring
variation of nuclear genes affecting mitochondrial function, i.e.,
mtDNA replication, transcription and translation as well as
polypeptides needed for TCA and OXPHOS, it is possible to
exploit the highly sophisticated genetic toolbox that exists for
D. melanogaster. With the binary gene expression systems, such
as GAL4-UAS, one can modify the expression of a desired
gene within a specific tissue within a specific time, providing a
route to investigate the effect of specific genes in chosen tissues
on a given phenotype (86). For example, overexpression and
gene knock-down methods could allow the modification of the
gene expression of nuclear encoded genes that are transported
to mitochondria, hence altering the mitochondrial function,
assuming that the mitochondrial import stage does not dampen
the effect of genetic modification.
Another approach to study mitochondrial variation is to focus
on naturally occurring variation in mtDNA. Investigating the
effect of mtDNA mutations is complicated by cross-talk between
the mitochondria and the nucleus of a cell, with nuclear genes
generally responsible for controlling mitochondrial activity. With
the cytoplasmic hybrid, aka. cybrid model, specific mtDNAs can
be introgressed onto controlled nuclear backgrounds, making it
possible to focus on the effects arising from the mitochondrial
genome (Figure 2). It is presently not possible to genetically
target and modify the gene expression of specific mtDNA genes,
and so the cybrid model relies on using natural mtDNA variants
found through different genetic screens. However, there are
methods for creating random mutations to mtDNA genome such
as using POLG mutants (87, 88) or to more specific regions with
targeted restriction enzymes (89).
By generating transmitochondrial cybrid cells, it is possible to
study the effects of mtDNA variation at the cellular level (78).
This in vitro approach has been used previously to investigate
the cellular effects of mtDNA polymorphism associated with an
aggressive form of breast cancer (90). Similarly, Bellizzi et al.,
hypothesized that the transcription of stress-responder nuclear
genes can be modulated according to the mtDNA variability.
They showed that osteosarcoma cells depleted of their own
mitochondria and repopulated with different ones, modulated
the expression of cytokines and cytokine receptors due to the
variability of the mtDNA (91).
The effects of mtDNA variation at the organismal level
may vary significantly from what can be inferred from cellular
level. The transmitochondrial in vitro method is limited in
investigating the impact of mtDNA variation affecting an entire
organism, for example upon environmental stress, limited diet
or when fighting infection. However, D. melanogaster offers a
feasible way of creating and utilizing cybrid strains for in vivo
experiments of the effects of mtDNA variation at the organismal
level (26, 30, 50), as well as quantifying the effects of mtDNA,
nDNA and their interaction. Given the ease with which flies can
be sampled from natural populations, options of screening the
mtDNA variation by sequencing and crossing and breeding the
lines in constant laboratory conditions, Drosophila cybrid lines
offer a unique opportunity to disentangle variation in immunity
arising from mtDNA polymorphism from the more commonly
investigated variation in nuclear-encoded genes associated with
canonical immune pathways.
There are three ways of creating cybrids and two of them,
repeated backcrossing and using balancer chromosomes, are
common methods in Drosophila, explained in detail below and
in Figure 2. In the third method, Mitochondrial Replacement
Therapy (MRT), mtDNA is introduced directly to a novel nuclear
environment. In MRT the nucleus of a mtDNA mutation bearing
female is transferred to an enucleated egg of a mitochondrially
healthy donor (92). To date, MRT has been performed in two
other mammalian species beside humans, in macaques (93) and
mice (94, 95).
Generating Drosophila Cybrids by
Repeated Backcrossing
Because mtDNA is inherited uniparentally through the mother,
the chosen donor mtDNA can be introgressed onto wanted
nuclear background by multiple generations of backcrossing
(Figure 2A). In the first cross the virgin females containing the
donor mtDNA are crossed with males containing the wanted
nuclear background, resulting in progeny with 100% maternal
mtDNA, 50% maternal nDNA and 50% paternal nDNA. This is
followed by a series of crosses where the virgin females of each
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A B
FIGURE 2 | Methods to generate Drosophila in vivo cybrid lines. (A) Repeated backcrossing. The chosen mtDNA variant is added during the first cross where the
virgin females from the mtDNA donor strain are crossed with the males of the nuclear donor strain. Virgin females of the following progeny are crossed again with the
males of the nuclear donor strain. This will be repeated for >15 generations, after which the cybrid progeny contain the wanted mtDNA variant on a nuclear
background that in theory is the same as the one in the nuclear donor strain. This method also has the potential to reveal possible mito-nuclear epistasis during the
course of the backcrossing. (B) Balancer chromosome method. Drosophila males do not go through recombination, whereas in females the recombination can be
controlled with the balancer chromosomes which do not recombine with the normal chromosome homologs during meiotic prophase. The presence of balancer
chromosomes in the progeny can be recognized by the dominant marker mutations that the balancers carry, e.g., mutations affecting eye shape, body color, or wing
morphology. If the progeny do not have the balancer, it has the normal homolog of the wanted chromosome. Three (labeled here a,a,a or b,b,b) of the four D.
melanogaster chromosomes can be replaced to contain the genetic content of the wanted nuclear donor strain by using the balancer chromosome method. The
mtDNA from the maternal donor strain is introgressed to the strain during the first cross and the chromosome content is replaced chromosome at a time by using
the correct progeny of the previous cross. For clarity, chromosomes 2 and 3 have not been marked to the cross where the X(a) is replaced with the X(b).
generation are crossed with males of the nuclear donor strain.
With each cross, the proportion of paternal nDNA increases
by 50% from the previous generation, meaning that in theory,
after 10 generations of backcrossing, less than 0.1% of the
maternal nDNA should be present. An important caveat to
introgression by repeated backcrossing is that although in theory
only 10 generations should be required to obtain a line over
99.9% of the paternal nuclear genome, in practice this value
will be lower due to strong linkage disequilibrium between loci
that have a close genetic distance (called linkage drag) (96).
From a mapping perspective this linkage can be advantageous,
but the backcrossing approach has the potential to select for
compatible nuclear partners, masking true incompatibilities (also
lethal combinations). The number of generations of backcrossing
required to break linkage between two loci will therefore depend
on the genetic distance such that the number of backcrosses
N = Log(1-r)(1-P) where r is the recombination frequency,
and P is the probability of separation (97). For example, for
two loci separated by a 20 cM interval, at least 17 generations
of backcrossing are required to have a 95% certainty of a
crossover event (97). However, even after multiple generations
of backcrossing, some loci are likely to never recombine if they
result in strongly deleterious or even lethal phenotypes, and such
loci will remain a source of residual heterozygosity regardless of
the number of generations of backcrossing.
This method has been used in D. melanogaster experiments
to study the effect of mito-nuclear interactions on mtDNA
copy number, respiration, development time and weight (40)
as well as in experiments where the effect of mtDNA variants
on mitochondrial diseases has been assayed in combination
with the balancer chromosome method (55, 98). The method
has been also employed in other insect species where the
use of balancer chromosomes is not possible, where the
effect of mito-nuclear crosstalk has been studied on traits
such as metabolism and aging in D. simulans (99), metabolic
rate in Drosophila subobscura (100), and personality (101),
bioenergetics, aging, life history traits (102), and male mating
costs (47) in seed beetles.
Utilizing Drosophila Balancer
Chromosomes
Drosophila has four chromosomes that include the X/Y sex
chromosome pair and autosomal chromosomes 2, 3, and 4.
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The fourth chromosome is very small, contains only around
80 genes (103) and does not recombine. The genetic tool
box developed for D. melanogaster allows the replacement
of the entire chromosomes with the wanted content of
specific strains or mutation. This is done with the help
of balancer chromosomes. Balancer chromosomes (104) are
multiply inverted and scrambled chromosomes that are not able
to undergo crossover with their normal chromosome homologs.
They also contain genetic markers that enable the recognition
of their segregation. As the small chromosome 4 does not go
through crossing over there are no balancers designed for this
chromosome. Nuclear genomes can be constructed by replacing
the chromosomes in multiple crosses in a properly planned
crossing scheme, and eventually controlling the nuclear genome
(Figure 2B). For creating Drosophila lines that contain the
wanted mtDNA variant on a controlled nuclear background, the
first cross includes the mtDNA donor females after which the
wild-type chromosomes will be replaced one by one with the
wanted isogenic chromosomes [crossing scheme explained e.g.,
in (30, 105, 106)]. This method has been utilized to study the
effect of mtDNA variation and mito-nuclear interaction on aging
(105), sex differences in aging, respiration and fertility (107, 108),
starvation resistance, lipid proportion and physical activity (106)
as well as ROS production and mtDNA copy number (109).
CONCLUSION AND FUTURE
PERSPECTIVES
Drosophila has contributed significantly for our understanding
of mitochondrial variation in both mitochondrial diseases and
in immunity. Here we have highlighted strengths of this
experimental powerhouse and described approaches that will
link these two important fields to address the question how
mitochondrial variation and specifically mtDNA variation affect
innate immune functions. This is significant because a number
of mitochondrial mutations have been associated with increased
susceptibility to infection in humans (110, 111) and recent
genetic screens have revealed vast variation in Drosophila mtDNA
(112). The Drosophila model will also be relevant in the context of
mitochondrial replacement therapy as a tool to test for potential
incompatibilities that may result from specific mito-nuclear
combinations (113). Given the homology between vertebrate
and invertebrate innate immunity (114), the Drosophila model
has the translational potential to generate novel candidate genes
originating from mitochondrial sources of disease susceptibility
and resistance, and for development of new therapeutic targets.
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